AARTIPHARMBSEAarti Pharmalabs LtdLowNeutral
Announced Tue, 26 May · 22:14 IST

Audio Recording of Conference Call for Investor and Analysts

Investor Communications View source PDF

AARTIPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-6.9%1-day move
₹694.65
prior close
₹694.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-1.1-0.8-1.3-6.9-7.6-8.4-10.5-7.6-12.5-5.1-2.4-1.7
Up moveDown movePending
AI summary

Aarti Pharmalabs has uploaded the audio recording of its Q4 and full-year FY26 earnings conference call on its website. The call was held following the company's audited financial results for the quarter and year ended March 31, 2026. The recording is accessible via the company's investor relations section at aartipharmalabs.com. This is a routine regulatory disclosure under SEBI LODR Regulation 30, ensuring transparency and accessibility of management commentary for investors and analysts.

Likely market impact

No new material information is contained in this filing. Investors who missed the live call can now access management's commentary on FY26 performance. The actual content of the call (including any guidance or forward-looking statements) resides in the audio file, not in this announcement itself.